Cresco Labs (CRLBF) Stock Forecast & Price Target

$0.95 0.00 (0.00%)

(As of 12/17/2024 ET)

Cresco Labs - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 8 Analyst Ratings

Sell
0

Hold
4

Buy
4

Based on 8 Wall Street analysts who have issued ratings for Cresco Labs in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 4 have given a hold rating, 2 have given a buy rating, and 2 have given a strong buy rating for CRLBF.

Consensus Price Target

$2.50
163.16% Upside

According to the 8 analysts' twelve-month price targets for Cresco Labs, the average price target is $2.50. The highest price target for CRLBF is $3.00, while the lowest price target for CRLBF is $2.00. The average price target represents a forecasted upside of 163.16% from the current price of $0.95.

Get the Latest News and Ratings for CRLBF and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cresco Labs and its competitors.

CRLBF Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$2.50	$2.50	$2.50	$8.38
Forecasted Upside	163.16% Upside	92.31% Upside	51.52% Upside	489.79% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Buy	Hold

Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available

CRLBF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRLBF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cresco Labs Stock vs. The Competition

Type	Cresco Labs	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	163.16% Upside	28,675.54% Upside	12.02% Upside
News Sentiment Rating	Neutral News See Recent CRLBF News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/9/2024	Atb Cap Markets 5 of 5 stars	F. Gomes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
11/11/2024	Cormark 3 of 5 stars	J. Pytlak Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Moderate Buy ➝ Hold
11/10/2024	Roth Capital 2 of 5 stars	W. Kirk Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/12/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mcginley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold
8/9/2024	Ventum Cap Mkts Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Semple Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/16/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$2.50 ➝ $3.00	+43.54%
3/14/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$1.75 ➝ $2.00	+5.82%
3/13/2024	Echelon Wealth Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Semple Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
8/17/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		C$2.00 ➝ C$1.50
8/16/2023	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		C$5.00 ➝ C$4.00
2/27/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral
2/24/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight	$14.25	+700.56%
12/20/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:21 PM ET.

CRLBF Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Cresco Labs is $2.50, with a high forecast of $3.00 and a low forecast of $2.00.
: 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 4 hold ratings, 2 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRLBF shares.
: According to analysts, Cresco Labs's stock has a predicted upside of 163.16% based on their 12-month stock forecasts.
: Over the previous 90 days, Cresco Labs's stock had 2 downgrades and 1 upgrade by analysts.
: Cresco Labs has been rated by research analysts at Atb Cap Markets, Cormark, and Roth Capital in the past 90 days.
: Analysts like Cresco Labs less than other "medical" companies. The consensus rating score for Cresco Labs is 2.75 while the average consensus rating score for "medical" companies is 2.81. Learn more on how CRLBF compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

This page (OTCMKTS:CRLBF) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cresco Labs (CRLBF) Stock Forecast & Price Target